Recursion Pharmaceuticals, Inc. SEC filings RXRX
Recursion Pharmaceuticals, Inc. has 991 filings in SEC EDGAR's recent list, going back to Apr 2, 2014. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 2, 2026 | Oct 31, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
|
Oct 15, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 21, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 30, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 25, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 25, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Other events
|
Nov 26, 2025 | Nov 26, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 5, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Other events
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K/A |
Amended current report
Unregistered share sale, Other events
|
Aug 29, 2025 | Jul 8, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure, Other events
|
Jul 8, 2025 | Jul 8, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Jun 10, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Other events
|
May 9, 2025 | May 9, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2025 | May 5, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Mar 18, 2025 | Mar 15, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 28, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Other events
|
Dec 17, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 3, 2024 | Dec 2, 2024 |
| 8-K/A | Amended current report | Nov 27, 2024 | Nov 19, 2024 |
| 8-K/A |
Amended current report
Unregistered share sale
|
Nov 26, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change, Regulation FD disclosure, Other events
|
Nov 20, 2024 | Nov 19, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 13, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Other events
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 6, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 2, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 3, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Other events
|
Aug 28, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Aug 8, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Other events
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Other events
|
Jun 27, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 24, 2024 | Jun 24, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Auditor change, Officer or director change, Regulation FD disclosure
|
May 24, 2024 | May 21, 2024 |
| 8-K |
Current report
Results of operations, Auditor change, Regulation FD disclosure
|
May 9, 2024 | May 7, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 16, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 7, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 31, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 20, 2023 | Dec 20, 2023 |
| 8-K |
Current report
Other events
|
Dec 15, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 2, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2023 | Sep 5, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Aug 11, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 12, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 13, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Other events
|
Jun 9, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 25, 2023 | May 25, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 17, 2023 | May 16, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 27, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Other events
|
Jan 25, 2023 | Jan 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2023 | Jan 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Oct 25, 2022 | Oct 24, 2022 |
| 8-K |
Current report
Other events
|
Sep 13, 2022 | Sep 13, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Other events
|
Jun 21, 2022 | Jun 20, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2022 | Jun 14, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 9, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Other events
|
Apr 11, 2022 | Apr 11, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 23, 2022 | Mar 23, 2022 |
| 8-K |
Current report
Other events
|
Mar 18, 2022 | Mar 18, 2022 |
| 8-K |
Current report
Other events
|
Mar 3, 2022 | Mar 3, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 7, 2021 | Dec 5, 2021 |
| 8-K |
Current report
Other events
|
Dec 6, 2021 | Dec 2, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Other events
|
Oct 7, 2021 | Oct 7, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2021 | Sep 9, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2021 | Aug 13, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 13, 2021 | Jul 13, 2021 |
| 8-K |
Current report
Results of operations
|
May 12, 2021 | May 12, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Apr 21, 2021 | Apr 20, 2021 |
Showing 90 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- RXRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Salt Lake City, UT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1601830
- Former names
- Recursion Pharmaceuticals, LLC (until Dec 4, 2015)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.